Cygenex is pleased to announce that Charles Clark, MBA, CSM, PMC-III, CEO of Cygenex, will present at the Society of Professional Benefit Administrators (SPBA) 2026 Fall Meeting in Nashville, Tennessee.
The two-day event, taking place September 24–25 at the Hilton Nashville Downtown, will bring together leaders from across the third-party administrator (TPA) and self-funded health plan community to discuss emerging trends and challenges shaping the future of healthcare.
Exploring the Role of Pharmacogenomics in Personalized Care
On Friday, September 25, from 11:00 AM to 12:00 PM CT, Charles will lead a session on Precision Medicine, exploring how pharmacogenomics can provide personalized insights into the way an individual’s genetic makeup may influence their response to medications.
Pharmacogenomics examines how variations in a person’s genes can affect their response to certain medications. These insights can help healthcare providers make more informed treatment decisions, including identifying medications that may be more effective for an individual and recognizing potential adverse reactions before they occur.
During the session, attendees will explore how pharmacogenomic insights can help:
- Predict whether a medication may be effective for a particular individual
- Identify potential adverse medication reactions
- Provide healthcare professionals with additional information to support more personalized treatment decisions
- Improve medication safety and effectiveness
- Advance a more individualized, data-driven approach to healthcare
Precision Medicine and the Future of Self-Funded Healthcare
For self-funded health plans and the organizations that support them, precision medicine represents an opportunity to rethink the traditional one-size-fits-all approach to medication management.
By better understanding how an individual’s genetic profile may influence medication response, pharmacogenomics has the potential to support better-informed prescribing decisions, improve patient outcomes, and help reduce avoidable costs associated with ineffective medications and adverse drug reactions.
This approach reflects Cygenex’s commitment to making precision medicine practical and accessible—turning complex genetic information into actionable insights that can support patients, healthcare providers, and health plans.
Join Us in Nashville
We look forward to joining SPBA members and industry leaders for an important conversation about the evolving role of precision medicine in healthcare.
SPBA 2026 Fall Meeting
September 24–25, 2026
Hilton Nashville Downtown
Precision Medicine Session
Friday, September 25
11:00 AM–12:00 PM CT
Presented by Charles Clark, MBA, CSM, PMC-III, CEO of Cygenex
To learn more about the SPBA 2026 Fall Meeting and registration, visit the Society of Professional Benefit Administrators website.
